Dose-escalated radiation therapy for intermediate-risk prostate cancer
Open Access
- 6 April 2009
- Vol. 115 (8) , 1784-1790
- https://doi.org/10.1002/cncr.24176
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate CancerJournal of Urology, 2008
- Optimized Prostate Brachytherapy Minimizes the Prognostic Impact of Percent of Biopsy Cores Involved With AdenocarcinomaJournal of Urology, 2007
- Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial InfarctionsJournal of Clinical Oncology, 2007
- Androgen deprivation therapy for prostate cancer: new concepts and concernsCurrent Opinion in Endocrinology, Diabetes and Obesity, 2007
- Long-Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate CancerJournal of Urology, 2006
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2006
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02Journal of Clinical Oncology, 2003
- Comparison of Preoperative Prostate Specific Antigen Density and Prostate Specific Antigen for Predicting Recurrence After Radical Prostatectomy: Results from the Search Data BaseJournal of Urology, 2003
- PERCENT PROSTATE NEEDLE BIOPSY TISSUE WITH CANCER IS MORE PREDICTIVE OF BIOCHEMICAL FAILURE OR ADVERSE PATHOLOGY AFTER RADICAL PROSTATECTOMY THAN PROSTATE SPECIFIC ANTIGEN OR GLEASON SCOREJournal of Urology, 2002